Ledger.Open graph →
SEC Form D · Amendment · filed April 11, 2019

Phoenix Life Sciences International Limited

Offering
$100.0M
Sold
$880K
Exemption
Rule 506(b)
Industry
Other Health Care
Location
DENVER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Martin H. Tindall · Salt Ash, Channel IslandsExec · DirectorKyle Mathews · San Francisco, CAExec · DirectorRaphael A. Schorr · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗